Inhibition of programmed death ligand 1 (PD-L1) expression in breast cancer cells by sesamin

• Main Authors: Prachya Kongtawelert, Benjawan Wudtiwai, Thuzar Hla Shwe, Peraphan Pothacharoen, Thanyaluck Phitak
• Format: Journal
• Published: 2020
• Subjects: Immunology and Microbiology; Medicine; Pharmacology, Toxicology and Pharmaceutics
• Online Access: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85087655505&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/70646
• Institution: Chiang Mai University

© 2020 Elsevier B.V. Programmed death ligand 1 (PD-L1) is overexpressed in some metastatic breast cancer subtypes, specifically triple-negative breast cancer (TNBC). This feature can assist in the eradication of anti-tumor immunity, thereby enhancing the survival of the tumor. This study aims to exp...